NCT07565701: Safety and Efficacy of a Phased Transition From Epogen to Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Subjects Receiving In-Center Hemodialysis

Sponsor: Geoff Block. Phase: PHASE3. Conditions: Anemia Associated With Chronic Kidney Disease